CSL fell 6.3% today continuing its nasty downtrend, as the GLP-1 (obesity drugs) juggernaut continues to smash through the healthcare sector. It has already destroyed ResMed (RMD) and yesterday their five year study into the GLP-1 efficacy in treating chronic kidney disease and Type 2 diabetes was halted early because the results were so good. It is…
CBA had its AGM yesterday – the share price dropped 0.31% (hardly changed), with one broker saying there was "No new news". A fairly quiet affair. Just a lot of motherhood comments about assisting the cost of living pressures, holding a strong balance sheet, and remaining well placed heading into a lower growth environment. There…
Full year results were in line with expectations if not 2% or 3% better than some forecasts. The food division did better-than-expected with increased margins (up 76bp). Described as solid growth. Some brokers upped their target price ($38.50 to $41.30) most simply left among changed. Some brokers upgraded earnings (3%), others downgraded (2%). They didn’t…
BHP’s full year results confirmed that BHP is a long-duration trading stock, not a quality, reliable, and especially not a "hold forever" income stock as some people imagine. Despite the brand name there is nothing the company can do when iron ore prices fall 18% in six months, copper prices fall 12% and coal prices…
PE HISTORY The orange line is the share price – the blue line is the Forward PE history. The horizontal blue line is the average PE over the chart period. THE CHART There is a daily short-term buy signal on the chart. DIVIDENDS Going Ex-dividend on August 30. BROKER STUFF
WBC Broker stuff after results yesterday – still got a few more to come in.
We have caught the knife buying RMD for a trade after a 25% collapse in the share price, which, as you can see below, has broken a long-term uptrend. That sell-off came after recent results (August7 2023) which missed sales forecast by 2% and saw margins down 2.1% to 55.8%. Margins were the issue, although they were only 0.3% below expectations. Brokers adjusted numbers downwards after the results to account for narrower margins and higher costs (inflation). Risks include Philips getting back into the market and suggestions that weight loss drugs could take off which would reduce the need for…
CSL – Finally bottoming after the recent sell-off – derisked post results.
On my Australian arrival in 1994 one of the most noticeable differences between the share market in London and the share market in Australia was the Food Retail sector. And it hasn’t changed. In London you are spoilt for choice. At any one time within a five mile radius in central London you could find…
